Makino et al. [18] has shown that an EP1 antagonist, and a nonselective PG synthase inhibitor, markedly attenuate mesangial expansion, inhibits glomerular hypertrophy and proteinuria of diabetic nephropathy in rats. This evidence concerns the gene PTGER1 and diabetic kidney disease.